ANTICANCER COMPOSITION CONTAINING A TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND AN IMMUNE RESPONSE CONTROL POINT INHIBITOR Russian patent published in 2021 - IPC C12N7/00 C12N15/113 A61K38/19 

Abstract RU 2740713 C1

FIELD: biotechnology.

SUBSTANCE: described is an anticancer composition containing a tumor-specific oncolytic adenovirus and an immune response control point inhibitor. A recombinant adenovirus with inserted IL-12 and shVEGF or IL-12 and GM-CSF-RLX genes.

EFFECT: invention exhibits an excellent anti-cancer effect by enhancing immune functions, and has been confirmed, that such anticancer effect is markedly enhanced by simultaneous introduction of an immune response with an inhibitor of the control point, and thus the present invention can be used as a key technique in treating cancer.

10 cl, 1 ex, 23 dwg

Similar patents RU2740713C1

Title Year Author Number
ANTICANCER COMPOSITION CONTAINING TUMOR-SPECIFIC ONCOLYTIC ADENO VIRUS AND INHIBITOR OF CONTROL POINT OF IMMUNE RESPONSE 2018
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2777523C2
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX 2017
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2742726C2
ANTI-TUMOUR COMPOSITION 2019
  • Yun, Chae Ok
  • Oh, Eon Ju
RU2768287C1
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS 2009
  • Khemminki Akseli
  • Kanerva Anna
  • Cherullo Vinchentso
  • Pesonen Sari
RU2520823C2
BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS 2017
  • Kezada, Serkhio
  • Peggs, Karl
  • Arse Vargas, Frederik
RU2759970C2
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT 2012
  • Li, Sang Dzin
  • Kim,Jun Khee,
  • Kim,In Khoo
  • Choi,Kiung Kho
  • Chun,Kiung-Khee
RU2575620C2
CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION 2009
  • Bich Robert Patterson
  • Rid Tomas D.
RU2573912C2
ONCOLYTIC VIRUS FOR IMMUNOLOGIC CONTROL POINT MODULATORS EXPRESSION 2015
  • Silvestr Natali
  • Gejst Mishel
  • Rittner Karola
  • Marshan Zhan-Batist
  • Tiudelle Kristin
RU2696312C2
METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY 2017
  • Roth, Jack, A.
  • Ji, Lin
RU2755903C2
COMBINATION THERAPY USING REIC/DKK-3 GENE AND IMMUNE RESPONSE CHECKPOINT INHIBITOR 2017
  • Kumon Hiromi
  • Lowenthal Richard
RU2767997C2

RU 2 740 713 C1

Authors

Yun, Chae Ok

Ahn, Hyo Min

Dates

2021-01-20Published

2018-02-28Filed